why choose us

First received: July 25, 2022

Clinical Trial: Blood Biomarkers in Pediatric Kidney Transplant Recipients

Study Status: Completed

Recruit Status: RECRUITING

Condition: Rejection of Kidney Allograft

Study Type: OBSERVATIONAL


Official Title: Use of Blood Gene Expression Profile and Donor-derived Cell-free DNA to Monitor Response to Treatment After Biopsy-proven Acute Rejection in Pediatric Kidney Transplant Recipients

Brief Summary: The objective of the proposed study is to assess whether a blood biomarker can be used to monitor the response to rejection treatment in pediatric kidney transplant recipients with biopsy-proven acute cellular or antibody mediated rejection.The study hypothesizes that blood gene expression profile and donor-derived cell-free DNA biomarkers (omnigraf) can be used to predict acute rejection and monitor its response to treatment.

Read more